AUVEN THERAPEUTICS HOLDINGS LP 13D and 13G filings for ADC Therapeutics SA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-25 4:10 pm Sale |
2024-04-23 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 2,255,719 2.700% |
-4,074,829 (-64.37%) |
Filing |
| 2023-04-28 4:08 pm Unchanged |
2023-04-27 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.900% |
0 (Unchanged) |
Filing |
| 2023-02-06 2:56 pm Sale |
2023-02-02 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.900% |
-12,000,000 (-65.46%) |
Filing |
| 2022-12-22 7:30 pm Unchanged |
2022-12-22 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.800% |
0 (Unchanged) |
Filing |
| 2022-12-09 4:06 pm Sale |
2022-12-08 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.800% |
-3,088,182 (-14.42%) |
Filing |
| 2022-12-08 09:07 am Sale |
2022-12-08 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 21,418,730 27.800% |
-775,000 (-3.49%) |
Filing |
| 2020-10-13 5:26 pm Sale |
2020-10-09 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 22,193,730 28.900% |
-1,400,000 (-5.93%) |
Filing |
| 2020-05-29 11:54 am Purchase |
2020-05-19 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 23,593,730 33.400% |
23,593,730 (New Position) |
Filing |